Neal Stuart Penneys, Director at Winston Pharmaceuticals, Inc. (WPHM), bought 20,000 shares at $0.40 ($8K) on 2010-07-20, disclosed to the SEC on 2010-07-21.
Open-market purchase of $8k WPHM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.40 | 10,000 | $4K | 47.6% |
| 2 | $0.44 | 10,000 | $4K | 52.4% |
| Total | $0.42 avg | 20,000 | $8K | 100% |